Observation of emerging per- and polyfluoroalkyl substances (PFASs) in Greenland marine mammals

- The emerging PFASs, F-53B and PFBS, were detected in East Greenland marine mammals.
- F-53B and PFBS liver concentrations were 3-4 orders of magnitude lower than PFOS.
- Killer whales were exposed to 17 PFASs but patterns differed compared to ringed seals and polar bears.

The present pilot study examined emerging per- and polyfluoroalkyl substances (PFASs), i.e., a suite of short chain perfluoroalkyl acids (PFAAs), PFAA precursors and replacement chemicals, and legacy PFASs (long chain length PFAAs) in livers from ringed seals, polar bears and, for the first time, killer whales from East Greenland collected in 2012-2013. Among the emerging PFASs, perfluorobutanesulfonic acid (PFBS) and F-53B (a chlorinated polyfluorinated ether sulfonic acid) were detected in Arctic wildlife, albeit at concentrations approximately four orders of magnitude lower compared to perfluorooctanesulfonic acid (PFOS). PFOS was positively correlated with F-53B, but not PFBS in all three species. A total of 17 PFASs were detected in killer whales, including in a mother-fetus pair, demonstrating maternal transfer. ∑PFAS concentrations in killer whales (269 ± 90 ng/g) were comparable to concentrations found in ringed seals (138 ± 7 ng/g), however, an order of magnitude lower compared to concentrations found in polar bear livers (2336 ± 263 ng/g). Patterns of long chain PFAAs in killer whales differed from the pattern in ringed seals and polar bears. Of the monitored PFAA precursors, only perfluorooctanesulfonamide (FOSA) was detected in all three species, and FOSA/PFOS ratios and isomer patterns indicated that killer whales have a potential lower metabolic capacity to degrade FOSA compared to polar bears and ringed seals.

169